Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catumaxomab in non-muscle-invasive bladder cancer
NCT04799847Phase 2Unknown
- Sponsor
- LintonPharm Co., Ltd.
- Start
- Nov 2021
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
A Phase 2 trial of catumaxomab in non-muscle-invasive bladder cancer (NMIBC), sponsored by LintonPharm Co., Ltd.. Status: unknown.
02
Drugs
catumaxomab
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT04799847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04799847.